Journal of Capital Medical University ›› 2005, Vol. 26 ›› Issue (6): 755-757.

• 临床研究 • Previous Articles     Next Articles

Analgesic Effect of Transdermal Fentanyl to Moderate or Severe Cancer Patients Treated at Home

Ma Zhenshan1, Shao Jun1, Jia Aihua1, Ren Shuping2   

  1. 1. Department of Hospice, Beijing Tiantan Hospital, Capital University of Medical Sciences;2. Department of Pharmacy, Beijing Tiantan Hospital, Capital University of Medical Sciences
  • Received:2004-11-26 Revised:1900-01-01 Online:2005-12-24 Published:2005-12-24

Abstract: Objective To assess the analgesic effects of Transdermal Fentanyl(Durogesic) to moderate or severe cancer patients treated at home.Methods 116 moderate or severe cancer patients with pain received a pain relieving treatment offered by a group of qualified doctors.The trial dosage of Transdermal Fentanyl is 25 μg/h or dosages referred to a conversion formula from morphine to Transdermal Fentanyl.The plaster will be changed with a new one after every 72 h.Dosage could be adjusted according to patients'reaction.Results After follow-up interviews, the effects and adverse reactions of Durogesic were observed.98.27% of patients were observed to relieve pain and the quality of life was significantly improved after use of Transdermal Fentanyl.The minimum dosage of Transdermal Fentanyl was 25 μg/h and the maximum 375 μg/h, average time of treatment was(90.5) d.The main adverse reactions were dizziness, nausea, constipation and skin allergy.Conclusion In summary, Transdermal Fentanyl is a kind of ideal analgesic which has the advantage of convenience and low rate of adverse reactions.It suits moderate or severe cancer patients who treated at home.

Key words: transdermal fentanyl, cancer, pain, pain relief treatment, quality of life

CLC Number: